| __timestamp | AstraZeneca PLC | Dynavax Technologies Corporation |
|---|---|---|
| Wednesday, January 1, 2014 | 5579000000 | 84580000 |
| Thursday, January 1, 2015 | 5997000000 | 86943000 |
| Friday, January 1, 2016 | 5890000000 | 84493000 |
| Sunday, January 1, 2017 | 5757000000 | 64988000 |
| Monday, January 1, 2018 | 5932000000 | 74951000 |
| Tuesday, January 1, 2019 | 5958000000 | 62331000 |
| Wednesday, January 1, 2020 | 5991000000 | 28607000 |
| Friday, January 1, 2021 | 9736000000 | 32228000 |
| Saturday, January 1, 2022 | 9762000000 | 46600000 |
| Sunday, January 1, 2023 | 10935000000 | 54886000 |
| Monday, January 1, 2024 | 13583000000 |
Unveiling the hidden dimensions of data
In the ever-evolving landscape of pharmaceuticals, innovation is the key to staying ahead. AstraZeneca PLC and Dynavax Technologies Corporation, two giants in the industry, have shown contrasting approaches to research and development (R&D) investments over the past decade. From 2014 to 2023, AstraZeneca has consistently outpaced Dynavax in R&D spending, with a staggering 1,800% more investment on average. In 2023, AstraZeneca's R&D expenses peaked at approximately $10.9 billion, marking a 96% increase from 2014. In contrast, Dynavax's R&D spending saw fluctuations, peaking in 2015 but declining by 35% by 2023. This disparity highlights AstraZeneca's commitment to innovation, potentially driving its competitive edge in the market. As the pharmaceutical industry continues to face challenges and opportunities, these investment strategies could shape the future of healthcare breakthroughs.
Who Prioritizes Innovation? R&D Spending Compared for Eli Lilly and Company and AstraZeneca PLC
Research and Development Expenses Breakdown: AstraZeneca PLC vs Zoetis Inc.
R&D Insights: How AstraZeneca PLC and Bio-Techne Corporation Allocate Funds
AstraZeneca PLC vs Verona Pharma plc: Strategic Focus on R&D Spending
Who Prioritizes Innovation? R&D Spending Compared for AstraZeneca PLC and Rhythm Pharmaceuticals, Inc.
Research and Development: Comparing Key Metrics for AstraZeneca PLC and Iovance Biotherapeutics, Inc.
Who Prioritizes Innovation? R&D Spending Compared for AstraZeneca PLC and HUTCHMED (China) Limited
Research and Development Investment: AstraZeneca PLC vs Celldex Therapeutics, Inc.
Research and Development: Comparing Key Metrics for AstraZeneca PLC and Amphastar Pharmaceuticals, Inc.
Vertex Pharmaceuticals Incorporated or Dynavax Technologies Corporation: Who Invests More in Innovation?
R&D Insights: How Incyte Corporation and Dynavax Technologies Corporation Allocate Funds
R&D Insights: How Amneal Pharmaceuticals, Inc. and Dynavax Technologies Corporation Allocate Funds